Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?
Author:
Affiliation:
1. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora
Funder
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Link
http://academic.oup.com/cid/article-pdf/69/10/1665/30327497/ciz025.pdf
Reference14 articles.
1. Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: a systematic review;Bota;World J Hepatol,2013
2. Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET;Gordon;J Hepatol,2015
3. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis;Hezode;Gastroenterology,2014
4. Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis;Stine;Dig Dis Sci,2015
5. Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis;Soriano;Antivir Ther,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study;Hepatology International;2023-06-05
2. Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with protease inhibitors‐based direct‐acting antivirals?;Liver International;2022-03-16
3. Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation;Journal of Hepatology;2021-12
4. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients with Chronic HCV Infection;Journal of Clinical and Translational Hepatology;2021-01-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3